Nanjing Vishee Medical Technology Co Ltd (688580) - Total Assets
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) holds total assets worth CN¥1.79 Billion CNY (≈ $262.55 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 688580 cash generation efficiency for how efficiently the company converts equity into cash flow.
Nanjing Vishee Medical Technology Co Ltd - Total Assets Trend (2013–2025)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. See 688580 stock price and chart for real-time trading data and today's change.
Nanjing Vishee Medical Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Nanjing Vishee Medical Technology Co Ltd's total assets of CN¥1.79 Billion consist of 58.4% current assets and 41.6% non-current assets. Explore Nanjing Vishee Medical Technology Co Ltd (688580) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 53.6% |
| Accounts Receivable | CN¥17.10 Million | 0.9% |
| Inventory | CN¥42.21 Million | 2.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥130.37 Million | 6.8% |
| Goodwill | CN¥69.31 Million | 3.6% |
Asset Composition Trend (2013–2025)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanjing Vishee Medical Technology Co Ltd's current assets represent 58.4% of total assets in 2025, a decrease from 93.4% in 2013.
- Cash Position: Cash and equivalents constituted 53.6% of total assets in 2025, up from 11.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 1.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 6.8% of total assets.
Nanjing Vishee Medical Technology Co Ltd Competitors by Total Assets
Key competitors of Nanjing Vishee Medical Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Vieworks Co. Ltd
KQ:100120
|
Korea | ₩351.89 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
Nanjing Vishee Medical Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.38 | 6.98 | 13.27 |
| Quick Ratio | 8.98 | 6.72 | 12.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥859.67 Million | CN¥949.99 Million | CN¥1.26 Billion |
Nanjing Vishee Medical Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Nanjing Vishee Medical Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.40 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | CN¥1.91 Billion |
| Market Capitalization | $582.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nanjing Vishee Medical Technology Co Ltd's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nanjing Vishee Medical Technology Co Ltd's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nanjing Vishee Medical Technology Co Ltd (2013–2025)
The table below shows the annual total assets of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.91 Billion ≈ $279.35 Million |
+4.87% |
| 2024-12-31 | CN¥1.82 Billion ≈ $266.38 Million |
+0.79% |
| 2023-12-31 | CN¥1.81 Billion ≈ $264.28 Million |
+7.23% |
| 2022-12-31 | CN¥1.68 Billion ≈ $246.45 Million |
+2.77% |
| 2021-12-31 | CN¥1.64 Billion ≈ $239.80 Million |
+6.38% |
| 2020-12-31 | CN¥1.54 Billion ≈ $225.42 Million |
+281.09% |
| 2019-12-31 | CN¥404.22 Million ≈ $59.15 Million |
+31.09% |
| 2018-12-31 | CN¥308.36 Million ≈ $45.12 Million |
+25.06% |
| 2017-12-31 | CN¥246.57 Million ≈ $36.08 Million |
+45.29% |
| 2016-12-31 | CN¥169.71 Million ≈ $24.83 Million |
+33.90% |
| 2015-12-31 | CN¥126.74 Million ≈ $18.55 Million |
+55.82% |
| 2014-12-31 | CN¥81.34 Million ≈ $11.90 Million |
+13.77% |
| 2013-12-31 | CN¥71.50 Million ≈ $10.46 Million |
-- |
About Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) device, and MagNeuro ONE, a TMS therapy system with navigation for psychiatric and neurological applications. It also provides MagBelle, a pelvic floor muscle stimulator for the treatment of urinar… Read more